Skip to main content

Table 4 Percentage of patients with improved BMLs

From: Clinical effect of intramuscular calcitonin compared with oral celecoxib in the treatment of knee bone marrow lesions: a retrospective study

  Calcitonin (n = 66) Celecoxib (n = 57) P value
4 weeks 14 (21.21%) 4 (7.01%) 0.039
3 months 25 (37.88%) 9 (15.79%) 0.006
  1. BMLs bone marrow lesions